在临床稳定的COPD中,通常评估的生物标志物的三个月变异性
Seon Cheol Park1,2, Narongkorn Saiphoklang1,3, Jonathan Phillips4
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
概括
像FEV1和CAT分数这样的生物标志物在3个月的时间内对稳定的COPD患者可靠. 然而,一些炎症标志物和功能测试显示出更多的变化,特别是在慢性支气管炎患者中.
科学领域:
- 肺部医学 肺部医学
- 临床试验 临床试验
- 生物标志物研究 生物标志物研究
背景情况:
- 慢性阻塞性肺病 (COPD) 的临床决定依赖于连续的生理参数和生物标志物.
- 了解这些评估的可靠性对于有效的患者管理至关重要.
研究的目的:
- 在临床稳定的COPD患者中,在3个月的时间内评估通常评估的生物标志物的稳定性和可靠性.
- 确定哪些生物标志物表现出一致的测量,哪些可能表现出显著的变化.
主要方法:
- 在89名临床稳定的COPD患者中进行了观察前性队列研究.
- 评估的生物标志物包括肺功能 (FEV1),功能性表现 (6分钟步行距离),患者报告的结果 (SGRQ,CAT) 和血液炎症标志物 (CRP,乙氨基,ESR,WBC).
- 类内相关系数 (ICC) 用于确定基线和3个月后续测量之间的一致性.
主要成果:
- 对于FEV1 (0.96),SGRQ (0.98),CAT (0.93) 和CRP (0.90) 观察到非常好的协议 (高ICC).
- 与较少强大的协议的参数包括6分钟的步行距离 (0.75),乙素计数 (0.77),ESR (0.75),和白细胞计数 (0.48).
- 更大的生物标志物变异性与慢性支气管炎病史和更高的基线SGRQ和CAT得分有关.
结论:
- FEV1,SGRQ,CAT和CRP是稳定可靠的生物标志物,用于监测临床稳定的COPD患者在3个月内.
- 炎症标志物,如白细胞计数和功能测试,如6分钟步行距离,显示出更大的变化.
- 患者的特征,如慢性支气管炎和症状负担影响生物标志物的稳定性.
更多相关视频
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20COPD: Pathogenesis and Clinical Features
354
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
354
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
249
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
249